Potential utility of nano-based treatment approaches to address the risk ofHelicobacter pylori
- 17 October 2021
- journal article
- research article
- Published by Taylor & Francis Ltd in Expert Review of Anti-infective Therapy
- Vol. 20 (3), 407-424
- https://doi.org/10.1080/14787210.2022.1990041
Abstract
Helicobacter pylori (H. pylori) has occupied a significant place among infectious pathogens and it has been documented as a leading challenge due to its higher resistance to the commonly used drugs, higher adaptability, and lower targeting specificity of the available drugs. New treatment strategies are urgently needed in order to improve the current advancement in modern medicine. Nanocarriers have gained an advantage of drug encapsulation and high retention time in the stomach with a prolonged drug release rate at the targeted site. This article aims to highlight the recent advances in nanotechnology with special emphasis on metallic, polymeric, lipid, membrane coated, and target-specific nanoparticles (NPs), as well as, natural products for treating H. pylori infection. We discussed a comprehensive approach to understand H. pylori infection and elicits to rethink about the increasing threat posed by H. pylori and its treatment strategies. To address these issues, nanotechnology has got huge potential to combat H. pylori infection and has made great progress in the field of biomedicine. Moreover, combinatory studies of natural products and probiotics in conjugation with NPs have proven efficiency against H. pylori infection, with an advantage of lower cytotoxicity, minimal side effects, and stronger antibacterial potential.Keywords
This publication has 203 references indexed in Scilit:
- The Molecular Basis of Inactivation of Metronidazole-Resistant Helicobacter pylori Using Polyethyleneimine Functionalized Zinc Oxide NanoparticlesPLOS ONE, 2013
- Fifteen-Year Effects of Helicobacter pylori, Garlic, and Vitamin Treatments on Gastric Cancer Incidence and MortalityJNCI Journal of the National Cancer Institute, 2012
- Silver nanoparticle applications and human healthClinica Chimica Acta; International Journal of Clinical Chemistry, 2010
- Helicobacter pylori: gastric cancer and beyondNature Reviews Cancer, 2010
- The association of vacA genotype and Helicobacter pylori-related disease in Latin American and African populationsClinical Microbiology & Infection, 2009
- The association of vacA genotypes and Helicobacter pylori-related gastroduodenal diseases in the Middle EastEuropean Journal of Clinical Microbiology & Infectious Diseases, 2009
- Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissuesAdvanced Drug Delivery Reviews, 2009
- Mechanistic and Structural Analysis of Aminoglycoside N-Acetyltransferase AAC(6′)-Ib and Its Bifunctional, Fluoroquinolone-Active AAC(6′)-Ib-cr VariantBiochemistry, 2008
- Selective toxicity of zinc oxide nanoparticles to prokaryotic and eukaryotic systemsApplied Physics Letters, 2007
- Natural Products as Sources of New Drugs over the Last 25 YearsJournal of Natural Products, 2007